✦ LIBER ✦

Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide

✍ Scribed by Niemi, M

Book ID: 111726913
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 97 KB
Volume: 69
Category: Article
ISSN: 0009-9236
DOI: 10.1067/mcp.2001.115822

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of rifampin and mefenamic acid o

Effects of rifampin and mefenamic acid on the pharmacokinetics and pharmacodynamics of dapagliflozin

✍ Kasichayanula, S.; Liu, X.; Griffen, S. C.; LaCreta, F. P.; Boulton, D. W. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 605 KB

The effects ofCYP2C9andCYP2C19genetic po

The effects ofCYP2C9andCYP2C19genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects

✍ Bo Tan; Yi-Fan Zhang; Xiao-Yan Chen; Xiao-Hua Zhao; Guo-Xin Li; Da-Fang Zhong 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 194 KB

Enzyme induction in the elderly: Effect

Enzyme induction in the elderly: Effect of rifampin on the pharmacokinetics and pharmacodynamics of propafenone

✍ Dilger, K 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 63 KB

Influence of atorvastatin on the pharmac

Influence of atorvastatin on the pharmacokinetics and pharmacodynamics of glyburide in normal and diabetic rats

✍ Prasad Neerati; Jyothsna Gade 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Effects of Hypothermia on Pharmacokineti

Effects of Hypothermia on Pharmacokinetics and Pharmacodynamics

✍ Marcel P. H. van den Broek PharmD, Floris Groenendaal, Antoine C. G. Egberts, Ca 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 231 KB

The pharmacokinetics and pharmacodynamic

The pharmacokinetics and pharmacodynamics of 12 weeks of glyburide therapy in obese diabetics

✍ L. A. Jaber; E. J. Antal; R. L. Slaughter; I. R. Welshman 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 544 KB

We have studied the pharmacokinetics and pharmacodynamics of glyburide during long-term therapy in 20 patients with type II diabetes mellitus. The patients were divided according to body mass index (BMI) into an obese group [n = 12, age 55(13) y, BMI 36.2(9.2) kg.m-2, total body weight (TBW) 100(23)